The IASLC Lung Cancer Staging Project: "the nodal zone".

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Comparison Between Lymph Node Station- and Zone-Based Classification: An Extended Analysis With the Ninth Edition TNM Lymph Node Descriptors in Surgically Resected NSCLC.JTO clinical and research reports · 2026
   Article
2. Differences in the Prognostic Impact between Single-Zone and Multi-Zone N2 Node Metastasis in Patients with Station-Based Multiple N2 Non-Small Cell Lung Cancer.Cancer research and treatment · 2025
   Article
3. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Overview of Challenges and Opportunities in Revising the Nodal Classification of Lung Cancer.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2023
   Review
4. High expression of Stabilin-2 predicts poor prognosis in non-small-cell lung cancer.Bioengineered · 2021
   Article
5. Discrimination of mediastinal metastatic lymph nodes in NSCLC based on radiomic features in different phases of CT imaging.BMC medical imaging · 2020
   Article
6. Tumor angiogenesis as an important prognostic factor in advanced non-small cell lung cancer (Stage IIIA).Oncology letters · 2018
   Article
7. Application of the new 8th TNM staging system for non-small cell lung cancer: treated with curative concurrent chemoradiotherapy.Radiation oncology (London, England) · 2017
   Article

Corrections and comments

• Comment on
  The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer.2007

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as